SpringerLink
Log in

Ovarian teratomas: clinical features, imaging findings and management

  • Special Section: Ovarian Cancer
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Ovarian teratomas are the most common type of germ cell tumors. There are three major subtypes of ovarian teratomas including mature, immature, and monodermal teratomas. Ultrasound, computed tomography and magnetic resonance imaging can demonstrate specific imaging findings for mature teratoma. Imaging features of immature and monodermal teratomas are less specific, but a combination of clinical features and imaging findings can help in the diagnosis. Imaging is also very helpful in guiding management. In this article, we review the epidemiology, histopathology, clinical presentation, imaging features and management of ovarian teratomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

References

  1. Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475–90.

  2. Ohama K. Androgenesis and parthenogenesis in humans. Human genetics. 1987:245–9.

  3. Surti U, Hoffner L, Chakravarti A, Ferrell RE. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. American journal of human genetics. 1990;47(4):635.

  4. Evers M, Rechnitzer C, Graem N, Skov Wehner P, Schroeder H, Rosthoej S, et al. Epidemiological study of paediatric germ cell tumours revealed the incidence and distribution that was expected, but a low mortality rate. Acta Paediatrica. 2017;106(5):779–85.

  5. DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. Clinical gynecologic oncology e-book: Elsevier Health Sciences; 2017.

  6. Damjanov I, Linder J, Anderson WAD. Anderson's pathology: Mosby; 1996.

  7. Ayhan A, Bukulmez O, Genc C, Karamursel BS, Ayhan A. Mature cystic teratomas of the ovary: case series from one institution over 34 years. European Journal of Obstetrics & Gynecology and reproductive biology. 2000;88(2):153–7.

  8. Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. 1971;27(2):343–8.

  9. Peterson WF, Prevost EC, Edmunds FT, Hundley Jr JM, Morris FK. Benign cystic teratomas of the ovary: a clinico-statistical study of 1,007 cases with a review of the literature. American journal of Obstetrics and Gynecology. 1955;70(2):368–82.

  10. Whitecar P, Turner S, Higby K. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. American journal of obstetrics and gynecology. 1999;181(1):19–24.

  11. Comerci JJ, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstetrics and gynecology. 1994;84(1):22–8.

  12. Ray-Coquard I, Trama A, Seckl M, Fotopoulou C, Pautier P, Pignata S, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. European Journal of Surgical Oncology. 2019;45(1):67–74.

  13. Soslow RA, Tornos C. Diagnostic pathology of ovarian tumors: Springer Science & Business Media; 2011.

  14. Vicus D, Beiner ME, Clarke B, Klachook S, Le LW, Laframboise S, et al. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Gynecologic oncology. 2011;123(1):50–3.

  15. Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. International Journal of Gynecological Pathology. 2009;28(5):405–22.

  16. Yoo S-C, Chang K-H, Lyu M-O, Chang S-J, Ryu H-S, Kim H-S. Clinical characteristics of struma ovarii. Journal of gynecologic oncology. 2008;19(2):135–8.

  17. Roth LM, Talerman A. The enigma of struma ovarii. Pathology. 2007;39(1):139-46.

  18. Carcangiu M, Kurman RJ, Carcangiu ML, Herrington CS. WHO classification of tumours of female reproductive organs: International Agency for Research on Cancer; 2014.

  19. Kleinman GM, Young RH, Scully RE. Primary neuroectodermal tumors of the ovary. A report of 25 cases. The American journal of surgical pathology. 1993;17(8):764–78.

  20. Kurman RJ. Blaustein's pathology of the female genital tract: Springer Science & Business Media; 2013.

  21. Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN, et al. Pathology and classification of ovarian tumors. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;97(S10):2631–42.

  22. Saba L, Guerriero S, Sulcis R, Virgilio B, Melis G, Mallarini G. Mature and immature ovarian teratomas: CT, US and MR imaging characteristics. European journal of radiology. 2009;72(3):454–63.

  23. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases. Cancer. 1976;37(5):2359–72.

  24. O'Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists. 1994;13(4):283–9.

  25. Michael H, Hull MT, Ulbright TM, Foster RS, Miller KD. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. The American journal of surgical pathology. 1997;21(8):896–904.

  26. Szyfelbein WM, Young RH, Scully RE. Struma ovarii simulating ovarian tumors of other types. A report of 30 cases. The American journal of surgical pathology. 1995;19(1):21–9.

  27. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Pathology Patterns Reviews. 2001;115(suppl_1):S94-S112.

  28. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet Neurology. 2008;7(12):1091–8.

  29. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists. 1993;12(4):333–43.

  30. Chaowalit N, Connolly HM, Schaff HV, Webb MJ, Pellikka PA. Carcinoid heart disease associated with primary ovarian carcinoid tumor. The American journal of cardiology. 2004;93(10):1314–5.

  31. SiNha NK. Struma ovarii with elevated ca-125 levels and ascites mimicking advanced ca ovary. Journal of clinical and diagnostic research: JCDR. 2014;8(3):140.

  32. Chen C, Li J-D, Huang H, Feng Y-L, Wang L-H, Chen L. Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary. Ai zheng= Aizheng= Chinese journal of cancer. 2008;27(1):92–5.

  33. Kikkawa F, Nawa A, Tamakoshi K, Ishikawa H, Kuzuya K, Suganuma N, et al. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998;82(11):2249–55.

  34. Emin U, Tayfun G, Cantekin I, Ozlem UB, Umit B, Leyla M. Tumor markers in mature cystic teratomas of the ovary. Archives of Gynecology and Obstetrics. 2009;279(2):145–7.

  35. Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Journal of clinical oncology. 1999;17(7):2137–43.

  36. Young RH. New and unusual aspects of ovarian germ cell tumors. The American journal of surgical pathology. 1993;17(12):1210–24.

  37. Teale E, Gouldesbrough DR, Peacey SR. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid. 2006;16(8):791–3.

  38. Yaegashi N, Tsuiki A, Shimizu T, Kobayashi N, Sato S, Namiki T, et al. Ovarian carcinoid with severe constipation due to peptide YY production. Gynecologic oncology. 1995;56(2):302–6.

  39. Sporrong B, Falkmer S, Robboy SJ, Alumets J, Hakanson R, Ljungberg O, et al. Neurohormonal peptides in ovarian carcinoids: An immunohistochemical study of 81 primary carcinoids and of intraovarian metastases from six mid‐gut carcinoids. Cancer. 1982;49(1):68–74.

  40. Quinn S, Erickson S, Black W. Cystic ovarian teratomas: the sonographic appearance of the dermoid plug. Radiology. 1985;155(2):477–8.

  41. Sheth S, Fishman EK, Buck J, Hamper UM, Sanders R. The variable sonographic appearances of ovarian teratomas: correlation with CT. American Journal of Roentgenology. 1988;151(2):331–4.

  42. Patel MD, Feldstein VA, Lipson SD, Chen DC, Filly RA. Cystic teratomas of the ovary: diagnostic value of sonography. AJR American journal of roentgenology. 1998;171(4):1061–5.

  43. Dodd 3rd G, Budzik Jr R. Lipomatous tumors of the pelvis in women: spectrum of imaging findings. AJR American journal of roentgenology. 1990;155(2):317–22.

  44. Vyas B, Dyer RB. The “dot–dash” sign. Abdominal imaging. 2015;40(7):2901–2.

  45. Beller MJ. The" tip of the iceberg" sign. Radiology. 1998;209(2):395–6.

  46. Kumar GA, Rajeev M, Mohit A. Sonographic spectrum of ovarian dermoid. Journal Of Obstetrics And Gynecology Of India. 2005;55(2):170–3.

  47. Tongsong T, Wanapirak C, Khunamornpong S, Sukpan K. Numerous intracystic floating balls as a sonographic feature of benign cystic teratoma: report of 5 cases. Journal of ultrasound in medicine. 2006;25(12):1587–91.

  48. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB. Transvaginal ultrasonography in the diagnosis of cystic teratoma. Obstetrics & Gynecology. 1995;85(1):48–52.

  49. Hertzberg BS, Kliewer M. Sonography of benign cystic teratoma of the ovary: pitfalls in diagnosis. AJR American journal of roentgenology. 1996;167(5):1127–33.

  50. Guttman Jr PH. In search of the elusive benign cystic ovarian teratoma: application of the ultrasound “tip of the iceberg” sign. Journal of Clinical Ultrasound. 1977;5(6):403–6.

  51. Friedman AC, Pyatt RS, Hartman D, Downey Jr E, Olson W. CT of benign cystic teratomas. American Journal of Roentgenology. 1982;138(4):659–65.

  52. Guinet C, Ghossain MA, Buy J-N, Malbec L, Hugol D, Truc JB, et al. Mature cystic teratomas of the ovary: CT and MR findings. European journal of radiology. 1995;20(2):137–43.

  53. Guinet C, Buy J-N, Ghossain MA, Malbec L, Hugol D, Truc JB, et al. Fat suppression techniques in MR imaging of mature ovarian teratomas: comparison with CT. European journal of radiology. 1993;17(2):117–21.

  54. Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19(2):373–82.

  55. Buy J, Ghossain M, Moss A, Bazot M, Doucet M, Hugol D, et al. Cystic teratoma of the ovary: CT detection. Radiology. 1989;171(3):697–701.

  56. Kim H-C, Kim S, Lee HJ, Shin SJ, Hwang S-I, Choi YH. Fluid–fluid levels in ovarian teratomas. Abdominal imaging. 2002;27(1):100–5.

  57. Togashi K, Nishimura K, Itoh K, Fujisawa I, Sago T, Minami S, et al. Ovarian cystic teratomas: MR imaging. Radiology. 1987;162(3):669–73.

  58. Brammer 3rd H, Buck J, Hayes W, Sheth S, Tavassoli F. From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation. Radiographics. 1990;10(4):715–24.

  59. Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 2002;22(6):1305–25.

  60. Ueno T, Tanaka YO, Nagata M, Tsunoda H, Anno I, Ishikawa S, et al. Spectrum of germ cell tumors: from head to toe. Radiographics. 2004;24(2):387–404.

  61. Yamaoka T, Togashi K, Koyama T, Fujiwara T, Higuchi T, Iwasa Y, et al. Immature teratoma of the ovary: correlation of MR imaging and pathologic findings. European radiology. 2003;13(2):313–9.

  62. England R, Desouza N, Kaye S. Gliomatosis peritonei: MRI appearances and its potential role in follow up. The British journal of radiology. 2007;80(953):e101-e4.

  63. Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29(2):347–73.

  64. Okamoto D, Ishigami K, Yoshimitsu K, Irie H, Tajima T, Asayama Y, et al. Gliomatosis peritonei associated with immature ovarian teratoma: a mimicker of peritoneal dissemination of malignant diseases. Journal of computer assisted tomography. 2007;31(2):317–9.

  65. Balink H, Apperloo MJ, Collins J. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT. Clinical nuclear medicine. 2012;37(8):804–6.

  66. Yamanaka Y, Tateiwa Y, Miyamoto H, Umemoto Y, Takeuchi Y, Katayama K, et al. Preoperative diagnosis of malignant transformation in mature cystic teratoma of the ovary. European journal of gynaecological oncology. 2005;26(4):391–2.

  67. Yokoyama T, Takehara K, Yamamoto Y, Okame S, Shiroyama Y, Yokoyama T, et al. The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas. International journal of clinical oncology. 2015;20(5):960–6.

  68. Cho A, Kim S-w, Choi J, Kang W, Lee J-d, Yun M. The additional value of attenuation correction CT acquired during 18F-FDG PET/CT in differentiating mature from immature teratomas. Clinical Nuclear Medicine. 2014;39(3):e193-e6.

  69. De Giorgi U, Pupi A, Fiorentini G, Rosti G, Marangolo M. FDG-PET in the management of germ cell tumor. Annals of Oncology. 2005;16(suppl_4):iv90-iv4.

  70. Yamashita Y, Hatanaka Y, Takahashi M, Miyazaki K, Okamura H. Struma ovarii: MR appearances. Abdominal imaging. 1997;22(1):100–2.

  71. Matsumoto F, Yoshioka H, Hamada T, Ishida O, Noda K. Struma ovarii: CT and MR findings. Journal of computer assisted tomography. 1990;14(2):310–2.

  72. Joja I, Asakawa T, Mitsumori A, Nakagawa T, Hiraki Y, Kudo T, et al. Struma ovarii: appearance on MR images. Abdominal imaging. 1998;23(6):652–6.

  73. Matsuki M, Kaji Y, Matsuo M, Kobashi Y. Struma ovarii: MRI findings. The British journal of radiology. 2000;73(865):87–90.

  74. Jung SI, Kim YJ, Lee MW, Jeon HJ, Choi J-S, Moon MH. Struma ovarii: CT findings. Abdominal imaging. 2008;33(6):740-3.

  75. Díaz-Montes TP, Rosenthal LE, Bristow RE, Grumbine FC. Primary insular carcinoid of the ovary. Gynecologic oncology. 2006;101(1):175–8.

  76. Aslam M, Choi C, Khulpateea N. Neuroendocrine tumour of the ovary. Journal of Obstetrics and Gynaecology. 2009;29(5):449–51.

  77. Tanaka YO, Ide Y, Nishida M, Nishide K, Tsunoda H, Kajitani M, et al. Ovarian tumor with functioning stroma. Computerized medical imaging and graphics. 2002;26(3):193–7.

  78. Choudhary S, Fasih N, Innes MM, Marginean C. Imaging of ovarian teratomas: appearances and complications. Journal of medical imaging and radiation oncology. 2009;53(5):480–8.

  79. Kim SH, Kim YJ, Park BK, Cho JY, Kim BH, Byun JY. Collision tumors of the ovary associated with teratoma: clues to the correct preoperative diagnosis. Journal of computer assisted tomography. 1999;23(6):929–33.

  80. Srisajjakul S, Prapaisilp P, Bangchokdee S. Imaging features of unusual lesions and complications associated with ovarian mature cystic teratoma. Clinical imaging. 2019;57:115–23.

  81. Kawakami S, Togash K, Egawa H, Kimura I, Fukuoka M, Mori T, et al. Solid mature teratoma of the ovary: appearances at MR imaging. Computerized medical imaging and graphics. 1994;18(3):203–7.

  82. Pantoja E, Noy M, Axtmayer R, Colon F, Pelegrina I. Ovarian dermoids and their complications comprehensive historical review. Obstetrical & gynecological survey. 1975;30(1):1–20.

  83. Fibus TF. Intraperitoneal rupture of a benign cystic ovarian teratoma: findings at CT and MR imaging. American Journal of Roentgenology. 2000;174(1):261–2.

  84. Lee AR, Kim K, Lee B, Chin S. Massive edema of the ovary: imaging findings. AJR American journal of roentgenology. 1993;161(2):343–4.

  85. Rha SE, Byun JY, Jung SE, Jung JI, Choi BG, Kim BS, et al. CT and MR imaging features of adnexal torsion. Radiographics. 2002;22(2):283–94.

  86. Kimura I, Togashi K, Kawakami S, Takakura K, Mori T, Konishi nJ. Ovarian torsion: CT and MR imaging appearances. Radiology. 1994;190(2):337–41.

  87. MATZ MH. Benign cystic teratomas of the ovary. Obstetrical & gynecological survey. 1961;16(5):591–605.

  88. Amérigo J, Nogales Jr FF, Fernandez-Sanz J, Oliva H, Velasco A. Squamous cell neoplasms arising from ovarian benign cystic teratoma. Gynecologic oncology. 1979;8(3):277–83.

  89. Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecologic oncology. 2007;105(2):321–4.

  90. Mlikotic A, McPhaul L, Hansen GC, Sinow RM. Significance of the solid component in predicting malignancy in ovarian cystic teratomas: diagnostic considerations. Journal of ultrasound in medicine. 2001;20(8):859–66.

  91. Kido A, Togashi K, Konishi I, Kataoka M, Koyama T, Ueda H, et al. Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR American journal of roentgenology. 1999;172(2):445–9.

  92. Park SB, Kim JK, Kim K-R, Cho K-S. Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data. Archives of gynecology and obstetrics. 2007;275(1):25–31.

  93. Han NY, Sung DJ, Park BJ, Kim MJ, Cho SB, Kim KA, et al. Imaging features of growing teratoma syndrome following a malignant ovarian germ cell tumor. Journal of computer assisted tomography. 2014;38(4):551–7.

  94. Aide N, Comoz F, Sevin E. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence? Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007;25(28):4494–6.

  95. Dalmau J, Tüzün E, Wu Hy, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma. Annals of neurology. 2007;61(1):25–36.

  96. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.

  97. MacGregor C, Cronin B. Evaluation and Management of Adnexal Masses. Topics in Obstetrics & Gynecology. 2016;36(2):1–6.

  98. Caspi B, Appelman Z, Rabinerson D, Zalel Y, Tulandi T, Shoham Z. The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women. Fertility and sterility. 1997;68(3):501–5.

  99. Howard F. Surgical management of benign cystic teratoma. Laparoscopy vs. laparotomy. The Journal of reproductive medicine. 1995;40(7):495–9.

  100. Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantu MG, Mangioni C. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstetrics and gynecology. 1994;84(4):598–604.

  101. Heifetz SA, Cushing B, Giller R, Shuster JJ, Stolar CJ, Vinocur CD, et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. The American journal of surgical pathology. 1998;22(9):1115–24.

  102. Oudoux A, Leblanc E, Beaujot J, Gauthier-Kolesnikov H. Treatment and follow-up of malignant struma ovarii: Regarding two cases. Gynecologic oncology reports. 2016;17:56–9.

  103. Somak R, Shramana M, Vijay S, Nita K. Primary carcinoid tumor of the ovary: a case report. Archives of gynecology and obstetrics. 2008;277(1):79–82.

  104. Zhu Y, Meng F, Fang H, Zhang Z, Wang L, Zheng W. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary. International Journal of Gynecologic Cancer. 2020;30(2):207–12.

Download references

Funding

No financial support.

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    Mohammed Saleh, Priya Bhosale, Corey Jensen & Revathy Iyer

  2. Department of Radiology, Mayo Clinic in Arizona, 13400 E. Shea Blvd., Scottsdale, AZ, 85259, USA

    Christine O. Menias

  3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    Preetha Ramalingam

  4. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Unit 1473, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA

    Dhakshinamoorthy Ganeshan

Authors
  1. Mohammed Saleh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priya Bhosale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine O. Menias
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Preetha Ramalingam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Corey Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Revathy Iyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dhakshinamoorthy Ganeshan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version.

Corresponding author

Correspondence to Dhakshinamoorthy Ganeshan.

Ethics declarations

Conflict of interest

No potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saleh, M., Bhosale, P., Menias, C.O. et al. Ovarian teratomas: clinical features, imaging findings and management. Abdom Radiol 46, 2293–2307 (2021). https://doi.org/10.1007/s00261-020-02873-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02873-0

Keywords

Search

Navigation